Zimmer Biomet Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Zimmer Biomet Holdings Inc. (ZBH) shares fell 3.24% to $91.03 on Tuesday, underperforming the broader market as the S&P 500 and Dow Jones rose. This decline ended a three-day winning streak. Compared to competitors like Johnson & Johnson, Medtronic, and Stryker, ZBH's performance was mixed, though all peers also declined. Trading volume of 3.2 million exceeded the 50-day average. The stock remains 15.94% below its 52-week high.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zimmer Biomet Holdings Inc. (ZBH) shed 3.24% to $91.03 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.38% to 7,543.59 and the Dow Jones Industrial Average rising 0.02% to 52,508.27.
The stock's fall snapped a three-day winning streak.
Zimmer Biomet Holdings Inc. closed 15.94% below its 52-week high of $108.29, which the company reached on August 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 1.52% to $253.85, Medtronic PLC (MDT) fell 5.11% to $79.30, and Stryker Corp. (SYK) fell 6.15% to $311.07.
Trading volume (3.2 M) eclipsed its 50-day average volume of 2.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-14-26 1708ET